Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Mol Cancer Ther. 2015 Jun 15;14(8):1824–1836. doi: 10.1158/1535-7163.MCT-14-0980-T

Table 2.

Pathway analysis for genes differentially expressed in MDA-MB-231 cells treated with selamectin

Canonical Pathway Z- score P value
Integrin-linked kinase (ILK) signaling −0.229 4.61E-05
PTEN signalling 0.577 2.36E-03
Growth hormone signaling −1.134 5.54E-03
Role of p14/p19ARF in tumor supression 0.447 5.84E-03
Estrogen-dependent breast cancer signaling NA 1.06E-02
Hepatocyte growth factor (HGF) signaling −0.707 2.25E-02
Fibroblast growth factor (FGF) signaling −1.134 4.98E-02